These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3561097)

  • 1. [Immunogenicity and protective properties for mice of the formalin-inactivated tick-borne encephalitis virus].
    Gut W; Jarzabek Z; Sadowski W; Kańtoch M
    Med Dosw Mikrobiol; 1986; 38(4):234-40. PubMed ID: 3561097
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis].
    Nikonova AN; Rozhkova LV; Sokolova ED
    Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis].
    Sokolova ED
    Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preventive vaccination against early summer meningoencephalitis].
    Kunz C
    Ther Umsch; 1983 Mar; 40(3):236-8. PubMed ID: 6304930
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic immunization against tick-borne encephalitis virus].
    Mitrofanova EE; Bakhvalova VN; Dobrikova EIu; Pap VA; Morozova OV
    Mol Biol (Mosk); 1997; 31(3):403-6. PubMed ID: 9297083
    [No Abstract]   [Full Text] [Related]  

  • 11. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against tick-borne encephalitis using the Soviet liquid inactivated vaccine].
    Plesník V; Januska J; Matuska J
    Cesk Epidemiol Mikrobiol Imunol; 1984 Nov; 33(6):338-45. PubMed ID: 6239701
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of the response of mice with temporary immunodepression to the administration of live or inactivated vaccine against tick-borne encephalitis].
    Vargin VV; Semenov BF
    Vopr Virusol; 1979; (1):52-7. PubMed ID: 217179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of neurovirulence, stability, and immunogenicity of attenuated variants of TP-21 Langat virus].
    Sokolova ED; Kamalov II; Konovalov GV
    Vopr Virusol; 1994; 39(5):220-3. PubMed ID: 7716907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis].
    Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD
    Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.